southphos aluminium phosphide tablets
envirofume limited - aluminium phosphide - aluminium phosphide 570 g/kg - insecticide
angeliq 1/2 tablet blister pack
bayer australia ltd - estradiol hemihydrate, quantity: 1.033 mg (equivalent: estradiol, qty 1 mg); drospirenone, quantity: 2 mg - tablet, film coated - excipient ingredients: povidone; hypromellose; magnesium stearate; lactose monohydrate; purified talc; macrogol 6000; titanium dioxide; pregelatinised maize starch; maize starch; iron oxide red - hormone replacement therapy (hrt) for use in the short-term treatment in postmenopausal women with an intact uterus of the climacteric syndrome caused by deficient endogenous oestrogen production due to natural menopause, hypogonadism, castration or primary ovarian failure.
topaal chewable tablets 30/40/200/ milligram tablets chewable
pierre fabre medicament - aluminium hydroxide gel, dried magnesium carbonate light alginic acid silica colloidal hydrated - tablets chewable - 30/40/200/ milligram
mylanta double strength
johnson & johnson (new zealand) limited - aluminium hydroxide 80 mg/ml (added as aluminium / magnesium co-gel c655); magnesium hydroxide 80 mg/ml (added as aluminium / magnesium co-gel c655); simeticone 6 mg/ml (added as mg/ml of simethicone emulsion 30%) - oral suspension - active: aluminium hydroxide 80 mg/ml (added as aluminium / magnesium co-gel c655) magnesium hydroxide 80 mg/ml (added as aluminium / magnesium co-gel c655) simeticone 6 mg/ml (added as mg/ml of simethicone emulsion 30%) excipient: acesulfame potassium butyl hydroxybenzoate enhancer flavour fadp925 (natural sweetness) ethanol ethyl hydroxybenzoate mint flavour sn011397 propyl hydroxybenzoate purified water sorbitol xanthan gum xylitol
mylanta original
johnson & johnson (new zealand) limited - aluminium hydroxide 40 mg/ml (added as (10.85% aloh dried ) aluminium / magnesium co-gel c655, 9.4% overage); magnesium hydroxide 40 mg/ml (added as (10.85% mgoh) as aluminium / magnesium co-gel c655, 9.4% overage); simeticone 4 mg/ml (added as 13.3 mg/ml of simethicone emulsion 30%) - oral suspension - active: aluminium hydroxide 40 mg/ml (added as (10.85% aloh dried ) aluminium / magnesium co-gel c655, 9.4% overage) magnesium hydroxide 40 mg/ml (added as (10.85% mgoh) as aluminium / magnesium co-gel c655, 9.4% overage) simeticone 4 mg/ml (added as 13.3 mg/ml of simethicone emulsion 30%) excipient: acesulfame potassium butyl hydroxybenzoate enhancer flavour fadp925 (natural sweetness) ethanol ethyl hydroxybenzoate mint flavour sn011397 propyl hydroxybenzoate purified water sorbitol xanthan gum xylitol - relief from indigestion, heartburn, upset stomach, flatulence and wind pain.
mylanta p
johnson & johnson (new zealand) limited - aluminium hydroxide 40 mg/ml (added as (10.85% aloh dried ) aluminium / magnesium co-gel c655, 9.4% overage); magnesium hydroxide 40 mg/ml (added as (10.85% mgoh dried ) aluminium / magnesium co-gel c655 9.4% overage); simeticone 4 mg/ml (added as 13.3 mg/ml of simethicone emulsion 30%) - oral suspension - active: aluminium hydroxide 40 mg/ml (added as (10.85% aloh dried ) aluminium / magnesium co-gel c655, 9.4% overage) magnesium hydroxide 40 mg/ml (added as (10.85% mgoh dried ) aluminium / magnesium co-gel c655 9.4% overage) simeticone 4 mg/ml (added as 13.3 mg/ml of simethicone emulsion 30%) excipient: acesulfame potassium butyl hydroxybenzoate enhancer flavour fadp925 (natural sweetness) ethanol ethyl hydroxybenzoate mint flavour sn011397 propyl hydroxybenzoate purified water sorbitol xanthan gum xylitol - relief from indigestion, heartburn, upset stomach, flatulence and wind pain.
idaman pharma magnesium trisilicate tablet compound
idaman pharma manufacturing sdn bhd - magnesium trisilicate; aluminium hydroxide -
cipla tenofovir + emtricitabine 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
cipla australia pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil fumarate, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised starch; croscarmellose sodium; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; triacetin; indigo carmine aluminium lake - treatment of hiv-1 infection: cipla tenofovir + emtricitabine 300/200 is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents. pre-exposure prophylaxis: cipla tenofovir + emtricitabine 300/200 is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in adults at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples.
tenofovir / emtricitabine sandoz 301/200 tenofovir disoproxil succinate / emtricitabine 301/200 mg film-coated tablet bottle
sandoz pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil succinate, quantity: 300.6 mg - tablet, film coated - excipient ingredients: macrogol 3350; indigo carmine aluminium lake; magnesium stearate; isopropyl alcohol; polyvinyl alcohol; microcrystalline cellulose; titanium dioxide; lactose monohydrate; purified talc; croscarmellose sodium; purified water; pregelatinised maize starch - treatment of hiv-1 infection,tenofovir/emtricitabine sandoz is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents.,pre-exposure prophylaxis,tenofovir/emtricitabine sandoz is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in adults at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples (see section 5.1 pharmacodynamic properties, clinical trials).
pritor/amlodipine 40 mg/10 mg telmisartan 40 mg/amlodipine (as besilate) 10 mg tablet blister pack
boehringer ingelheim pty ltd - telmisartan, quantity: 40 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, multilayer - excipient ingredients: colloidal anhydrous silica; sodium hydroxide; sorbitol; magnesium stearate; pregelatinised maize starch; povidone; microcrystalline cellulose; maize starch; meglumine; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination. (see dosage and administration)